Nisa Investment Advisors, LLC Eli Lilly & CO Transaction History

Nisa Investment Advisors, LLC

$15.2 Billion
Q1 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 237,130 shares of LLY stock, worth $215 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

237,130

Previous 243,979 2.81%

Holding current value

$215 Million

Previous $142 Million 29.71%

% of portfolio

1.22%

Previous 1.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $4.06 Million - $5.43 Million	-6,849 Reduced 2.81%	237,130 $184 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $6.72 Million - $7.93 Million	-12,804 Reduced 4.99%	243,979 $142 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $1.21 Million - $1.67 Million	-2,793 Reduced 1.08%	256,783 $138 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $2.56 Million - $3.43 Million	7,305 Added 2.9%	259,576 $122 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $401,955 - $472,077	-1,294 Reduced 0.51%	252,271 $86.6 Million

Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $2.2 Million - $2.56 Million	-6,836 Reduced 2.63%	253,565 $92.8 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $6.18 Million - $7.04 Million	-20,846 Reduced 7.41%	260,401 $84.4 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $3.78 Million - $4.43 Million	13,550 Added 5.06%	281,247 $91.2 Million
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $4.86 Million - $6.04 Million	-20,716 Reduced 7.18%	267,697 $76.7 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $2.61 Million - $3.24 Million	11,600 Added 4.19%	288,413 $70.8 Million
Q3 2021 Oct 18, 2021	SELL	$221.6 - $272.71 $7.21 Million - $8.88 Million	-32,545 Reduced 10.52%	276,813 $64 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $8.63 Million - $11.2 Million	-47,799 Reduced 13.38%	309,358 $71 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $12.4 Million - $16.1 Million	-75,533 Reduced 17.46%	357,157 $66.7 Million
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $15.7 Million - $20.8 Million	-120,260 Reduced 21.75%	432,690 $73.1 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $20.8 Million - $24.1 Million	142,542 Added 34.73%	552,950 $81.8 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $2.99 Million - $3.6 Million	21,929 Added 5.64%	410,408 $67.4 Million
Q1 2020 Apr 17, 2020	BUY	$119.05 - $147.35 $1.57 Million - $1.94 Million	13,189 Added 3.51%	388,479 $53.9 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $382,880 - $474,231	-3,581 Reduced 0.95%	375,290 $49.3 Million
Q3 2019 Oct 17, 2019	SELL	$106.79 - $116.16 $1.13 Million - $1.23 Million	-10,609 Reduced 2.72%	378,871 $42.4 Million
Q2 2019 Jul 12, 2019	SELL	$110.79 - $129.32 $6.66 Million - $7.77 Million	-60,073 Reduced 13.36%	389,480 $43.2 Million
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $2.16 Million - $2.55 Million	-19,443 Reduced 4.15%	449,553 $58.3 Million
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $3.28 Million - $3.67 Million	-30,949 Reduced 6.19%	468,996 $54.3 Million
Q3 2018 Oct 16, 2018	BUY	$85.86 - $107.31 $9.66 Million - $12.1 Million	112,466 Added 29.03%	499,945 $53.6 Million
Q2 2018 Jul 19, 2018	BUY	$75.7 - $86.88 $728,915 - $836,567	9,629 Added 2.55%	387,479 $33.1 Million
Q1 2018 Apr 10, 2018	BUY	$74.21 - $87.6 $390,047 - $460,425	5,256 Added 1.41%	377,850 $29.2 Million
Q4 2017 Jan 12, 2018	BUY	$81.94 - $87.89 $3.14 Million - $3.37 Million	38,354 Added 11.47%	372,594 $31.5 Million
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $25.8 Million - $28.6 Million	334,240	334,240 $28.6 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Eli Lilly & CO Transaction History